NEW BATCH!

Rituximab

clinical grade

BATCH NUMBER: NB6052

320,00 €

Therapeutic Rituximab antibody from the biosimilar Rixathon® commercial drug
Request For Quotation
Bulk deal
Quantity Discount
5 - 9 5%
10 - 14 10%
15 - 24 15%
25 + 25%

.

In stock

Product specifications:​

  • Quality Standard clinical-grade
  • Product Concentration 10 mg/mL
  • Volume per vial 200 µL
  • Quantity per vial 2 mg
  • Origin of the commercial drug DE
  • Batch Number NB6052
  • Storage Temperature -80 °C
  • Original therapeutic expiry date: 2026.03

Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient administration and is not applicable to the shelf life of the aliquot. Aliquot storage at -86°C ensures fully functional molecules even after the mentioned expiry date.

Product Information:

Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.

As ‘raw material’ for the production of drug aliquots, Evidentic sources RMP from the European (EU) market. As a licensed pharmaceutical wholesaler, Evidentic is committed to Good Distribution Practice (GDP) compliance with respect to the procurement, storage and shipment of RMP.
Drug aliquots are manufactured by repackaging RMP in a qualified laboratory. The aliquotation process is performed under a quality and manufacturing agreement between Evidentic and the contract manufacturer. Repackaging of RMP includes the following steps: opening the secondary and primary RMP containers and transferring the specified volumes of RMP into an Eppendorf 0.5 ml low-binding (or similar) tube. If the RMP is a lyophilized powder and not a highly concentrated solution, reconstitute the RMP according to the original manufacturer’s instructions and then aliquot as a highly concentrated solution.
For identification purposes, drug aliquots are labeled with the date of aliquoting, the original lot number of the RMP, the original expiration date of the RMP, the name of the active ingredient (INN), and a unique identification code.
Immediately after aliquoting, drug aliquots are stored at either 2-8 °C or -86 °C for long-term storage. All drug aliquots stored at 2-8 °C are transferred to -86 °C at least two weeks before the expiration date of the original RLD/RMP is reached. Further quality or functional testing are not performed on the drug aliquots.  

Target

Class of molecule

,

Isotype

Host cells

Chinese Hamster Ovary (CHO) cells

Prepared from (Reference drug)​

Rixathon®

Therapeutic Area

,

Therapeutic Indications

, , , ,

Mechanism of Action (MoA)

Binds to CD20 on pre-B and mature B-cells inducing apoptosis and possibly ADCC and CDC.

Pharmacotherapeutic group​​

Antineoplastic agents

List of Excipients​

Sodium citrate (E 331)
Polysorbate 80 (E 433)
Sodium chloride
Sodium hydroxide (for pH adjustment) (E 524)
Hydrochloric acid (for pH adjustment) (E 507)
Water for injection

Batch specific analytical data available

Evidentic’s analytical service includes a comprehensive array of methods to support the drug development process, including, for example, structure, aggregation, degree of isomerization and N-glycans identification of the active pharmaceutical ingredient (API).

Rituximab

BATCH NUMBER: NB6052

Request an individual offer​

+ download a free sample​

1. Choose your(s) method(s) of interest
2. Provide your contact details
3. Send us your request and download a free sample report


Please provide your contact information


send us your inquiry and download a free sample file


  • Target research – Target identification, selection & validation
  • Planning and screening preparation
  • Lead generation – Screening preparation, hit generation, screening & lead selection
  • Lead optimization – Lead characterization, candidate selection
  • Preclinical development – PK/PD studies of candidate

More , , Reference Drugs as Aliquots

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
Adalimumab 1120078A
TNF alpha
Biosimilar
,
Monoclonal Antibody
Amgevita®
50 mg/mL
–
2 mg
-80°C
2021.12
304,00 €
view product
Max: 10
Min: 1
Step: 1
Adalimumab 1825216
TNF alpha
Biosimilar
,
Monoclonal Antibody
Hulio®
50 mg/mL
–
2 mg
-80°C
2023.02
304,00 €
view product
Max: 10
Min: 1
Step: 1
Adalimumab 1909689A
TNF alpha
Biosimilar
,
Monoclonal Antibody
Hukyndra®
100 mg/mL
–
2 mg
-80°C
2023.10
354,00 €
view product
Max: 10
Min: 1
Step: 1
Adalimumab 2LJPO1T11
TNF alpha
Biosimilar
,
Monoclonal Antibody
Yuflyma®
100 mg/mL
–
4 mg
-80°C
2024.02
354,00 €
view product
Max: 10
Min: 1
Step: 1
Adalimumab AU034994
TNF alpha
Biosimilar
,
Monoclonal Antibody
Idacio®
50 mg/mL
–
2 mg
-80°C
2023.10
355,00 €
view product
Max: 10
Min: 1
Step: 1
Adalimumab GR226512
TNF alpha
Biosimilar
,
Monoclonal Antibody
Imraldi®
50 mg/mL
–
2 mg
-80 °C
2023.10
304,00 €
view product
Max: 10
Min: 1
Step: 1
Adalimumab MA8208
TNF alpha
Biosimilar
,
Monoclonal Antibody
Hyrimoz®
50 mg/mL
–
2 mg
-80°C
2024.06
304,00 €
view product
Max: 10
Min: 1
Step: 1
Bevacizumab
VEGF-A
Monoclonal Antibody
Zirabev®
25 mg/mL
–
2 mg
tba
tba
200,00 €
view product
Max: 50
Min: 11
Step: 1
Bevacizumab
VEGF-A
Monoclonal Antibody
Oyavas®
25 mg/mL
–
2 mg
tba
tba
197,00 €
view product
Max: 50
Min: 11
Step: 1
Bevacizumab
VEGF-A
Monoclonal Antibody
Alymsys®
25 mg/mL
–
2 mg
tba
tba
197,00 €
view product
Max: 50
Min: 11
Step: 1
Bevacizumab
VEGF-A
Monoclonal Antibody
Aybintio®
25 mg/mL
–
2 mg
tba
tba
197,00 €
view product
Max: 50
Min: 11
Step: 1
Bevacizumab
VEGF-A
Monoclonal Antibody
Abevmy®
25 mg/mL
–
2 mg
tba
tba
207,00 €
view product
Max: 50
Min: 11
Step: 1
Bevacizumab
VEGF-A
Monoclonal Antibody
Vegzelma®
25 mg/mL
–
2 mg
tba
tba
198,00 €
view product
Max: 50
Min: 11
Step: 1
Eculizumab
C5 complement protein
Biosimilar
,
Monoclonal Antibody
Bekemv®
10 mg/mL
–
3 mg
tba
tba
391,00 €
view product
Max: 20
Min: 16
Step: 1
Eculizumab
C5 complement protein
Biosimilar
,
Monoclonal Antibody
Epysqli®
10 mg/mL
–
3 mg
tba
tba
391,00 €
view product
Max: 20
Min: 16
Step: 1
Epoetin Zeta 0o013U0
EPO receptor
Biosimilar
,
Glycoprotein hormone
Silapo®
40000 IU/mL
–
5000 IU
-80°C
2022.08
385,00 €
view product
Max: 9
Min: 1
Step: 1
Etanercept 2110190088
TNF alpha
Biosimilar
,
Fusion protein
Erelzi®
50 mg/mL
–
4 mg
-80°C
2023.04
272,00 €
view product
Max: 10
Min: 2
Step: 1
Etanercept GR206474
TNF alpha
Biosimilar
,
Fusion protein
Benepali®
50 mg/mL
–
4 mg
-80°C
2023.11
272,00 €
view product
Max: 10
Min: 2
Step: 1
Etanercept Y10005702
TNF alpha
Biosimilar
,
Fusion protein
Nepexto®
50 mg/mL
–
4 mg
-80 °C
2023.08
237,40 €
view product
Max: 10
Min: 2
Step: 1
Infliximab EC1216
TNF alpha
Biosimilar
,
Monoclonal Antibody
Flixabi®
10 mg/mL
–
2 mg
-80°C
2025.01
239,00 €
view product
Max: 10
Min: 2
Step: 1
Infliximab GF5988
TNF alpha
Biosimilar
,
Monoclonal Antibody
Inflectra®
10 mg/mL
–
2 mg
- 80°C
2027.03
240,00 €
view product
Max: 10
Min: 2
Step: 1
Ranibizumab
VEGF
Biosimilar
,
Monoclonal Antibody
Ximluci®
10 mg/mL
–
0,21 mg
tba
tba
680,00 €
view product
Max: 10
Min: 5
Step: 1
Ranibizumab
VEGF
Monoclonal Antibody
Byooviz®
10 mg/mL
–
0,21 mg
tba
tba
621,00 €
view product
Max: 10
Min: 5
Step: 1
Rituximab
CD20
Biosimilar
,
Monoclonal Antibody
Ruxience®
10 mg/mL
–
2 mg
tba
tba
196,00 €
view product
Max:
Min: 11
Step: 1
Rituximab
CD20
Biosimilar
,
Monoclonal Antibody
Truxima®
10 mg/mL
–
2 mg
tba
tba
234,00 €
view product
Max:
Min: 10
Step: 1
Rituximab H0203B05
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
–
2 mg
-80°C
2018.05
145,00 €
view product
Max: 10
Min: 3
Step: 1
Rituximab H0209B04
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
–
2 mg
-80°C
2018.09
145,00 €
view product
Max: 10
Min: 3
Step: 1
Rituximab N7129B16
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
–
2 mg
-80°C
2018.12
145,00 €
view product
Max: 10
Min: 3
Step: 1
Rituximab N7135B11
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
–
2 mg
-80°C
2019.02
145,00 €
view product
Max: 10
Min: 3
Step: 1
Rituximab N7135B18
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
–
2 mg
-80°C
2019.02
145,00 €
view product
Max: 10
Min: 3
Step: 1
1 2

VIEW MORE NEW BATCHES!

Not looking for Rituximab NB6052?

Search our therapeutic molecules product database

Quick Ordering

Find and order your therapeutic molecules through smart filters

Multiple Batches

Up to 10 batches of original drugs for examining batch-to-batch variations

Reduce Costs

Up to 80% less compared to the original pharmaceutical price

Worldwide Shipping

Shipment within days worldwide according to GDP-standards

Precise Quantity​​

Up to 80% less compared to the original pharmaceutical price

Evidentic GmbH
Am Mühlenberg 10

14476 Potsdam | Germany

+49 (0) 30 959 99 8831
info@evidentic.com

Cookie Preferences

Linkedin Youtube Facebook Twitter Instagram

Thank you for your interest in our services.

We will respond to you within one working day. You can now download your sample report.